BioSpace News Archive

TIGIT Inhibitor Emerging Role In Cancer Immunotherapy

First TIGIT Inhibitor Drug Is Expected To Enter The Market In Next 2 Years Says Kuick Research.

December 10, 2021
·
3 min read
FDA Approved Bispecific Antibodies Clinical Trials Market Insight 2028

Global Bispecific Antibodies Market Offers Billion Dollars Opportunity With 3 Approved Antibodies Says Kuick Research.

December 10, 2021
·
3 min read
Drug Development

Celcuity Presents Updated Results of Phase 1b Study of Gedatolisib in Combination with Palbociclib and Endocrine Therapy for ER+ Advanced Breast Cancer (ABC) at the 2021 San Antonio Breast Cancer Symposium

Celcuity Inc., a clinical-stage biotechnology company pursuing an integrated therapeutic and companion diagnostic strategy for treating patients with cancer, presented a poster at the 2021 San Antonio Breast Cancer Symposium with updated results from a four-arm Phase 1b expansion study.

December 10, 2021
·
9 min read
Business

Concord Medical Reports Financial Results for the First Half of 2021

Concord Medical Services Holdings Limited today announced its unaudited consolidated financial results for the six months ended June 30, 2021[1].

December 10, 2021
·
18 min read
Business

Lilly and Regor Therapeutics Group Enter into Strategic Collaboration to Discover and Develop Novel Therapies for Metabolic Disorders

Eli Lilly and Company (NYSE: LLY) and Regor Therapeutics Group have entered into a multi-year research collaboration and licensing agreement to discover, develop and commercialize novel therapies for metabolic disorders.

December 10, 2021
·
4 min read
BioMidwest

Kraig Biocraft Laboratories Spider Silk Featured on BBC Earth SeriesJon Rice, COO, Interview Clips Included in the Broadcast

Kraig Biocraft Laboratories, Inc. announces today that its spider silk was featured in a new episode of the BBC Earth’s “Inspired By Nature” series.

December 10, 2021
·
2 min read
Drug Development

UCB announces positive Phase 3 results for rozanolixizumab in generalized myasthenia gravis

Positive topline results from UCB MycarinG study investigating the efficacy and safety of rozanolixizumab in patients with generalized myasthenia gravis (gMG).

December 10, 2021
·
14 min read
Drug Development

Oncolytics Biotech® Presents Positive Interim Safety Update from Phase 2 Triple-Negative Breast Cancer Trial at the 2021 San Antonio Breast Cancer Symposium

Oncolytics Biotech ® Inc. announced a positive interim safety update from the investigator-sponsored, phase 2 IRENE trial in a poster presentation at the 2021 San Antonio Breast Cancer Symposium (SABCS).

December 10, 2021
·
6 min read
Business

Kezar Appoints Courtney Wallace to its Board of Directors

Kezar Life Sciences, Inc today announced the appointment of strategic business development executive Courtney Wallace to its Board of Directors.

December 10, 2021
·
2 min read
Drug Development

Moderna Announces Positive Interim Phase 1 Data for mRNA Flu Vaccine and Provides Program Update

Phase 1 study of quadrivalent flu vaccine (mRNA-1010) successfully boosted titers against all four strains in older and younger adults, even at lowest dose; no significant safety concerns were observed.

December 10, 2021
·
10 min read